Vincent Grégoire
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Vincent Grégoire has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
A Wambersie
Cliniques universitaires Saint-Luc, université catholique de Louvain, av Hippocrate, 10, 1200 Bruxelles, Belgique
7 shared publications- John Gueulette
Université Catholique de Louvain, Brussels, Belgium
7 shared publications - Xavier Geets
Molecular Imaging, Radiotherapy and Oncology (MIRO), UCLouvain, Brussels, Brussels, Belgium; Department of Radiation Oncology, Cliniques Universitaires Saint-Luc, Brussels, Belgium
5 shared publications M Beauduin
4 shared publicationsS Vynckier
4 shared publicationsB M De Coster
3 shared publications
Latest Publications
- 1 January 2014
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 111, S207
SP-0526: Translating hypoxia imaging into adaptive radiotherapy
- 1 January 2014
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 111, S207
SP-0526: Translating hypoxia imaging into adaptive radiotherapy
- 1 September 2013
- Vol. 57 (3) , 271-82
Implementation of hypoxia PET imaging in radiation therapy planning.
Hypoxia has historically been relevant to radiation oncology as it relates to radioresistance, poor response to therapy and unfavorable patient's outcome in many solid tumors. In that regard, the recent advances in imaging, computation and radiation delivery techniques have been offering new perspectives to prescribe and deliver radiation dose in accordance with the spatial distribution of hypoxia mapped with molecular or functional imaging modalities, i.e., the so-called dose painting (DP). At first glance, the concept of dose painting appears promising and let foresee likely improvement in tumor local control at an acceptable clinical cost. However, adapting radiotherapy planning and delivery according to hypoxia imaging implicitly assumes: 1) that the imaging variable actually correlates with a local biological property associated with individual therapy outcome; 2) that the spatial distribution of the imaging parameter can be adequately converted into dose; and 3) that an irradiation device can actually deliver such a heterogeneous dose in fractionated RT treatments. In that regard, many uncertainties and difficulties remain at each step of the DP process, mainly related to the limitations of the current imaging techniques and the treatment fractionation. This paper will thus review the state of the art of DP with a specific focus on hypoxia, going from cancer biology to adaptive dose delivery. It will address the technological challenges and the clinical validation, which are both essential to translate an intuitively appealing concept into a clinically meaningful practice.
- 1 September 2013
- Vol. 57 (3) , 271-82
Implementation of hypoxia PET imaging in radiation therapy planning.
Hypoxia has historically been relevant to radiation oncology as it relates to radioresistance, poor response to therapy and unfavorable patient's outcome in many solid tumors. In that regard, the recent advances in imaging, computation and radiation delivery techniques have been offering new perspectives to prescribe and deliver radiation dose in accordance with the spatial distribution of hypoxia mapped with molecular or functional imaging modalities, i.e., the so-called dose painting (DP). At first glance, the concept of dose painting appears promising and let foresee likely improvement in tumor local control at an acceptable clinical cost. However, adapting radiotherapy planning and delivery according to hypoxia imaging implicitly assumes: 1) that the imaging variable actually correlates with a local biological property associated with individual therapy outcome; 2) that the spatial distribution of the imaging parameter can be adequately converted into dose; and 3) that an irradiation device can actually deliver such a heterogeneous dose in fractionated RT treatments. In that regard, many uncertainties and difficulties remain at each step of the DP process, mainly related to the limitations of the current imaging techniques and the treatment fractionation. This paper will thus review the state of the art of DP with a specific focus on hypoxia, going from cancer biology to adaptive dose delivery. It will address the technological challenges and the clinical validation, which are both essential to translate an intuitively appealing concept into a clinically meaningful practice.
- Open Access
- 1 March 2013
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 106, S147-S148
SP-0378: PET for delineation in radiotherapy: Reliability and opportunities
- 1 March 2013
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 106, S147-S148
Open AccessSP-0378: PET for delineation in radiotherapy: Reliability and opportunities
- Open Access
- 1 March 2013
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 106, S340
PO-0877: QA for radiation therapy in a prospective head & neck study: Outcome impact of ICRs performed by the EORTC QART program
- 1 March 2013
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 106, S340
Open AccessPO-0877: QA for radiation therapy in a prospective head & neck study: Outcome impact of ICRs performed by the EORTC QART program
- 1 May 2012
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 103, S175-S176
PD-0441 TARGET VOLUME DELINEATION BASED ON 18FDG PET FOR LOCALLY ADVANCED HEAD AND NECK CANCER TREATED BY CHEMO-RADIOTHERAPY
- 1 May 2012
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 103, S175-S176
PD-0441 TARGET VOLUME DELINEATION BASED ON 18FDG PET FOR LOCALLY ADVANCED HEAD AND NECK CANCER TREATED BY CHEMO-RADIOTHERAPY
- 1 May 2012
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 103, S204
OC-0507 HOW MANY CHEMOTHERAPY CYCLES DURING CHEMORADIOTHERAPY FOR HEAD AND NECK CARCINOMA? A GORTEC TRIAL
- 1 May 2012
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 103, S204
OC-0507 HOW MANY CHEMOTHERAPY CYCLES DURING CHEMORADIOTHERAPY FOR HEAD AND NECK CARCINOMA? A GORTEC TRIAL
- 30 September 2011
- Published by Elsevier in European Journal of Cancer
- Vol. 47, S548
8515 POSTER DISCUSSION A Dose Escalation Study With Intensity Modulated Radiation Therapy (IMRT) in Moderately Advanced (T2N0, T2N1, T3N0) Squamous Cell Carcinomas (SCC) of the Oropharynx, Larynx and Hypopharynx Using a Simultaneous Integrated Boost (SIB) Approach
- 30 September 2011
- Published by Elsevier in European Journal of Cancer
- Vol. 47, S548
8515 POSTER DISCUSSION A Dose Escalation Study With Intensity Modulated Radiation Therapy (IMRT) in Moderately Advanced (T2N0, T2N1, T3N0) Squamous Cell Carcinomas (SCC) of the Oropharynx, Larynx and Hypopharynx Using a Simultaneous Integrated Boost (SIB) Approach
- 1 June 2011
- Published by Wiley in Medical Physics
- Vol. 38 (6Part35) , 3859
TH‐C‐214‐04: This House Believes That the Use of Functional Imaging for Treatment Planning of Head and Neck Tumors Needs to Be Carefully Considered
- 1 June 2011
- Published by Wiley in Medical Physics
- Vol. 38 (6Part35) , 3859
TH‐C‐214‐04: This House Believes That the Use of Functional Imaging for Treatment Planning of Head and Neck Tumors Needs to Be Carefully Considered
- 1 June 2011
- Published by Wiley in Medical Physics
- Vol. 38 (6Part23) , 3669
SU-E-T-774: on the Effects of Intrafraction Motion on TomoTherapy SIB Treatments of Lung Tumors: A 4D Monte Carlo Study including Non-Rigid Registration and Beamlet-Breathing Phase Correlation
- 1 June 2011
- Published by Wiley in Medical Physics
- Vol. 38 (6Part23) , 3669
SU-E-T-774: on the Effects of Intrafraction Motion on TomoTherapy SIB Treatments of Lung Tumors: A 4D Monte Carlo Study including Non-Rigid Registration and Beamlet-Breathing Phase Correlation
- 1 February 2005
- Published by Elsevier in Cancer/Radiothérapie
- Vol. 9 (1) , 42-50
Intensity Modulated Radiation Therapy in Head and Neck Squamous Cell Carcinoma: state of the art and future challenges
- 1 February 2005
- Published by Elsevier in Cancer/Radiothérapie
- Vol. 9 (1) , 42-50
Intensity Modulated Radiation Therapy in Head and Neck Squamous Cell Carcinoma: state of the art and future challenges